MetaADEDB 2.0 @ LMMD
Dronedarone
(ZQTNQVWKHCQYLQ-UHFFFAOYSA-N)
Structure
SMILES
CCCCc1oc2c(c1C(=O)c1ccc(cc1)OCCCN(CCCC)CCCC)cc(cc2)NS(=O)(=O)C
Type(s)
Approved
ATC code(s)
C01BD07
Molecular Formula:
C31H44N2O5S
Molecular Weight:
556.756
Log P:
8.2028
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
97.23
CAS Number(s):
141626-36-0
Synonym(s)
1.
Dronedarone
2.
Multaq
3.
SR 33589
4.
SR 33589B
External Link(s)
MeSHD000077764
PubChem Compound208898
BindingDB50151864
ChEBI50659
CHEMBLCHEMBL184412
DrugBankDB04855
DrugCentral4112
IUPHAR/BPS Guide to PHARMACOLOGY7465
KEGGdr:D02537
Therapeutic Target DatabaseD05CPV
ZINC49933061
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Atrial FibrillationFAERS: 33517804843
19213680
20628043
CTD
US FAERS
2Blood creatinine increasedFAERS: 108SIDER
US FAERS
3FatigueFAERS: 85SIDER
US FAERS
4NauseaFAERS: 8519213680CTD
SIDER
US FAERS
5AstheniaFAERS: 60
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
6DizzinessFAERS: 53US FAERS
7Drug ineffectiveFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
8MalaiseFAERS: 45US FAERS
9HeadacheFAERS: 37US FAERS
10Alanine Aminotransferase IncreasedFAERS: 30US FAERS
11PalpitationsFAERS: 29US FAERS
12Feeling abnormalFAERS: 27US FAERS
13PneumoniaFAERS: 25SIDER
US FAERS
14Aspartate Aminotransferase IncreasedFAERS: 24US FAERS
15PruritusFAERS: 23SIDER
US FAERS
16Pulmonary FibrosisFAERS: 23SIDER
US FAERS
17VomitingFAERS: 23SIDER
US FAERS
18Weight decreasedFAERS: 23US FAERS
19Cardiac ArrestFAERS: 22US FAERS
20Atrial FlutterFAERS: 20SIDER
US FAERS
21Abdominal discomfortFAERS: 19US FAERS
22HyperthyroidismFAERS: 19US FAERS
23SyncopeFAERS: 18US FAERS
24BradycardiaFAERS: 1719213680CTD
SIDER
US FAERS
25Cerebrovascular accidentFAERS: 17US FAERS
26Drug dose omissionFAERS: 17US FAERS
27PainFAERS: 16US FAERS
28Pulmonary toxicityFAERS: 16SIDER
US FAERS
29Urinary tract infectionFAERS: 16US FAERS
30WheezingFAERS: 16US FAERS
31Myocardial InfarctionFAERS: 15US FAERS
32Abdominal PainFAERS: 14SIDER
US FAERS
33AlopeciaFAERS: 14US FAERS
34Ejection Fraction DecreasedFAERS: 14US FAERS
35ErythemaFAERS: 13SIDER
US FAERS
36HypersensitivityFAERS: 13US FAERS
37Incorrect dose administeredFAERS: 13US FAERS
38Transaminases increasedFAERS: 13US FAERS
39TremorFAERS: 13US FAERS
40Wrong technique in product usage processFAERS: 13US FAERS
41ArthralgiaFAERS: 12US FAERS
42Chest discomfortFAERS: 12US FAERS
43HypotensionFAERS: 12US FAERS
44InfectionFAERS: 12US FAERS
45SepsisFAERS: 12US FAERS
46TachycardiaFAERS: 1210975596CTD
US FAERS
47Unevaluable eventFAERS: 12US FAERS
48BronchitisFAERS: 11US FAERS
49Gamma-Glutamyltransferase IncreasedFAERS: 11US FAERS
50PancreatitisFAERS: 11US FAERS
51FlatulenceFAERS: 10US FAERS
52Product quality issueFAERS: 10US FAERS
53Adverse eventFAERS: 9US FAERS
54Pulmonary HypertensionFAERS: 9US FAERS
55Ventricular FibrillationFAERS: 9US FAERS
56Visual ImpairmentFAERS: 9US FAERS
57AgeusiaFAERS: 8SIDER
US FAERS
58AnxietyFAERS: 8US FAERS
59Blood urea increasedFAERS: 8US FAERS
60Cardiac ablationFAERS: 8US FAERS
61DeafnessFAERS: 8US FAERS
62HepatitisFAERS: 8US FAERS
63LethargyFAERS: 8US FAERS
64MyalgiaFAERS: 8US FAERS
65Peripheral swellingFAERS: 8US FAERS
66Productive CoughFAERS: 8US FAERS
67UrticariaFAERS: 8US FAERS
68Acute kidney injuryFAERS: 720628043CTD
US FAERS
69AsthmaFAERS: 7US FAERS
70Back PainFAERS: 7US FAERS
71Blood alkaline phosphatase increasedFAERS: 7US FAERS
72Burning sensationFAERS: 7US FAERS
73Chest PainFAERS: 7US FAERS
74Creatinine renal clearance decreasedFAERS: 7US FAERS
75Drug administration errorFAERS: 7US FAERS
76HypoxiaFAERS: 7US FAERS
77Joint swellingFAERS: 7US FAERS
78Respiratory FailureFAERS: 7US FAERS
79SwellingFAERS: 7US FAERS
80TinnitusFAERS: 7US FAERS
81AngioedemaFAERS: 6SIDER
US FAERS
82Cardiac FlutterFAERS: 6US FAERS
83Medication residue presentFAERS: 6US FAERS
84NasopharyngitisFAERS: 6US FAERS
85Pericardial effusionFAERS: 6US FAERS
86Product dose omissionFAERS: 6US FAERS
87Rash erythematousFAERS: 6SIDER
US FAERS
88SinusitisFAERS: 6US FAERS
89TachyarrhythmiaFAERS: 6US FAERS
90Vitreous floatersFAERS: 6US FAERS
91Wrong technique in drug usage processFAERS: 6US FAERS
92jaundiceFAERS: 6US FAERS
93Angina PectorisFAERS: 5US FAERS
94ArthritisFAERS: 5US FAERS
95DehydrationFAERS: 5US FAERS
96DiverticulitisFAERS: 5US FAERS
97Dry skinFAERS: 5US FAERS
98DyspepsiaFAERS: 5SIDER
US FAERS
99Electrocardiogram abnormalFAERS: 5US FAERS
100General physical health deteriorationFAERS: 5US FAERS
101HepatotoxicityFAERS: 5US FAERS
102Joint injuryFAERS: 5US FAERS
103PolyneuropathyFAERS: 5US FAERS
104Renal painFAERS: 5US FAERS
105Respiratory distressFAERS: 5US FAERS
106SomnolenceFAERS: 5US FAERS
107Sudden deathFAERS: 5US FAERS
108Anorectal discomfortFAERS: 4US FAERS
109Atrioventricular BlockFAERS: 4US FAERS
110BlindnessFAERS: 4US FAERS
111Brain natriuretic peptide increasedFAERS: 4US FAERS
112ChromaturiaFAERS: 4US FAERS
113DysphoniaFAERS: 4US FAERS
114Electrocardiogram QT interval abnormalFAERS: 4US FAERS
115Eye painFAERS: 4US FAERS
116Fluid overloadFAERS: 4US FAERS
117GastritisFAERS: 4US FAERS
118HemicephalalgiaFAERS: 4US FAERS
119Impaired gastric emptyingFAERS: 4US FAERS
120Inappropriate schedule of drug administrationFAERS: 4US FAERS
121Intentional product misuseFAERS: 4US FAERS
122Limb discomfortFAERS: 4US FAERS
123Lipase increasedFAERS: 4US FAERS
124No adverse eventFAERS: 4US FAERS
125Pulmonary congestionFAERS: 4US FAERS
126Pulse waveform abnormalFAERS: 4US FAERS
127ScotomaFAERS: 4US FAERS
128Tooth InfectionFAERS: 4US FAERS
129VasculitisFAERS: 4SIDER
US FAERS
130AbasiaFAERS: 3US FAERS
131AgitationFAERS: 3US FAERS
132Atrial tachycardiaFAERS: 3US FAERS
133Blood amylase increasedFAERS: 3US FAERS
134Blood iron decreasedFAERS: 3US FAERS
135Blood thyroid stimulating hormone increasedFAERS: 3US FAERS
136Bowel movement irregularityFAERS: 3US FAERS
137CataractFAERS: 3US FAERS
138ChillsFAERS: 3US FAERS
139ConstipationFAERS: 3US FAERS
140CystitisFAERS: 3US FAERS
141CystFAERS: 3US FAERS
142Ear discomfortFAERS: 3US FAERS
143EructationFAERS: 3US FAERS
144Inability to afford medicationFAERS: 3US FAERS
145Medication ErrorFAERS: 3US FAERS
146Memory impairmentFAERS: 3US FAERS
147Myasthenia GravisFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
148NervousnessFAERS: 3US FAERS
149Optic NeuritisFAERS: 3US FAERS
150Optic NeuropathyFAERS: 3US FAERS
151Oropharyngeal painFAERS: 3US FAERS
152PO2 decreasedFAERS: 3US FAERS
153PleurisyFAERS: 3US FAERS
154Product counterfeitFAERS: 3US FAERS
155Product label issueFAERS: 3US FAERS
156Sick Sinus SyndromeFAERS: 3US FAERS
157Sinus ArrhythmiaFAERS: 3US FAERS
158Sinus bradycardiaFAERS: 3US FAERS
159Throat cancerFAERS: 3US FAERS
160Throat irritationFAERS: 3US FAERS
161ThrombocytopeniaFAERS: 3US FAERS
162VertigoFAERS: 3US FAERS
163AcneFAERS: 2US FAERS
164Activities of daily living impairedFAERS: 2US FAERS
165Acute Coronary SyndromeFAERS: 2US FAERS
166AmnesiaFAERS: 2US FAERS
167AphasiaFAERS: 2US FAERS
168ArthropathyFAERS: 2US FAERS
169Axonal neuropathyFAERS: 2US FAERS
170Blood creatine increasedFAERS: 2US FAERS
171Blood creatine phosphokinase increasedFAERS: 2US FAERS
172Blood creatinine abnormalFAERS: 2US FAERS
173Blood lactate dehydrogenase increasedFAERS: 2US FAERS
174Blood potassium increasedFAERS: 2US FAERS
175Blood sodium decreasedFAERS: 2US FAERS
176Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
177Bronchial irritationFAERS: 2US FAERS
178BursitisFAERS: 2US FAERS
179CardiomegalyFAERS: 2US FAERS
180CellulitisFAERS: 2US FAERS
181Choking sensationFAERS: 2US FAERS
182CholangitisFAERS: 2US FAERS
183Clostridium difficile infectionFAERS: 2US FAERS
184Deep Vein ThrombosisFAERS: 2US FAERS
185DeliriumFAERS: 2US FAERS
186Device pacing issueFAERS: 2US FAERS
187Diabetes MellitusFAERS: 2US FAERS
188DisabilityFAERS: 2US FAERS
189Disease ProgressionFAERS: 2US FAERS
190Drug chemical incompatibilityFAERS: 2US FAERS
191Drug prescribing errorFAERS: 2US FAERS
192DysarthriaFAERS: 2US FAERS
193DysgeusiaFAERS: 2SIDER
US FAERS
194EndocarditisFAERS: 2US FAERS
195EpistaxisFAERS: 2US FAERS
196Expired product administeredFAERS: 2US FAERS
197Extra dose administeredFAERS: 2US FAERS
198Hepatic congestionFAERS: 2US FAERS
199Hepatorenal SyndromeFAERS: 2US FAERS
200HypertransaminasaemiaFAERS: 2US FAERS
201HypoperfusionFAERS: 2US FAERS
202HypothyroidismFAERS: 2US FAERS
203Idiopathic Pulmonary FibrosisFAERS: 2US FAERS
204Increased upper airway secretionFAERS: 2US FAERS
205InfluenzaFAERS: 2US FAERS
206LeukopeniaFAERS: 2US FAERS
207Lip swellingFAERS: 2US FAERS
208Lung consolidationFAERS: 2US FAERS
209Macular degenerationFAERS: 2US FAERS
210Mental status changesFAERS: 2US FAERS
211OliguriaFAERS: 2US FAERS
212OnychoclasisFAERS: 2US FAERS
213OverdoseFAERS: 2US FAERS
214PhotophobiaFAERS: 2US FAERS
215PneumonitisFAERS: 2US FAERS
216Poor dental conditionFAERS: 2US FAERS
217Precancerous skin lesionFAERS: 2US FAERS
218PresyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Product use complaintFAERS: 2US FAERS
220Pulmonary function test decreasedFAERS: 2US FAERS
221PurpuraFAERS: 2US FAERS
222Quality of life decreasedFAERS: 2US FAERS
223RalesFAERS: 2US FAERS
224RosaceaFAERS: 2US FAERS
225SarcomaFAERS: 2US FAERS
226ScabFAERS: 2US FAERS
227Sinoatrial BlockFAERS: 2US FAERS
228Skin UlcerFAERS: 2US FAERS
229Supraventricular tachycardiaFAERS: 2US FAERS
230Unresponsive to stimuliFAERS: 2US FAERS
231Upper-airway cough syndromeFAERS: 2US FAERS
232Ventricular arrhythmiaFAERS: 2US FAERS
233prostatitisFAERS: 2US FAERS
234Accidental exposure to productFAERS: 1US FAERS
235Accidental overdoseFAERS: 1US FAERS
236Acute Lung InjuryFAERS: 1US FAERS
237Acute endocarditisFAERS: 1US FAERS
238Acute prerenal failureFAERS: 1US FAERS
239Acute respiratory failureFAERS: 1US FAERS
240Alcohol withdrawal syndromeFAERS: 1US FAERS
241Ammonia increasedFAERS: 1US FAERS
242AnosmiaFAERS: 1US FAERS
243AnoxiaFAERS: 1US FAERS
244AortitisFAERS: 1US FAERS
245AphagiaFAERS: 1US FAERS
246AphoniaFAERS: 1US FAERS
247Apparent deathFAERS: 1US FAERS
248Apparent life threatening eventFAERS: 1US FAERS
249AtelectasisFAERS: 1US FAERS
250Autoimmune hepatitisFAERS: 1US FAERS
251Autoimmune thyroiditisFAERS: 1US FAERS
252Blood cholesterol increasedFAERS: 1US FAERS
253Blood glucose decreasedFAERS: 1US FAERS
254Blood glucose increasedFAERS: 1US FAERS
255Blood potassium decreasedFAERS: 1US FAERS
256Blood pressure fluctuationFAERS: 1US FAERS
257Blood sodium abnormalFAERS: 1US FAERS
258Body temperature fluctuationFAERS: 1US FAERS
259Bone density decreasedFAERS: 1US FAERS
260Bone swellingFAERS: 1US FAERS
261BradyphreniaFAERS: 1US FAERS
262BronchospasmFAERS: 1US FAERS
263C-reactive proteinFAERS: 1US FAERS
264Candida pneumoniaFAERS: 1US FAERS
265ChokingFAERS: 1US FAERS
266CholecystitisFAERS: 1US FAERS
267CholelithiasisFAERS: 1US FAERS
268CholestasisFAERS: 1US FAERS
269Cholestatic liver injuryFAERS: 1US FAERS
270ChromatopsiaFAERS: 1US FAERS
271ConjunctivitisFAERS: 1US FAERS
272Contraindicated product administeredFAERS: 1US FAERS
273Corneal OpacityFAERS: 1US FAERS
274Creatinine renal clearance increasedFAERS: 1US FAERS
275Critical IllnessFAERS: 1US FAERS
276CyanosisFAERS: 1US FAERS
277DementiaFAERS: 1US FAERS
278Dental PlaqueFAERS: 1US FAERS
279Dental cariesFAERS: 1US FAERS
280Depressed Level of ConsciousnessFAERS: 1US FAERS
281Depressed moodFAERS: 1US FAERS
282Device battery issueFAERS: 1US FAERS
283Device capturing issueFAERS: 1US FAERS
284Device ineffectiveFAERS: 1US FAERS
285Device malfunctionFAERS: 1US FAERS
286Diabetic ulcerFAERS: 1US FAERS
287Diffuse Large B-Cell LymphomaFAERS: 1US FAERS
288DiplopiaFAERS: 1US FAERS
289DiscomfortFAERS: 1US FAERS
290Disease recurrenceFAERS: 1US FAERS
291Diverticular perforationFAERS: 1US FAERS
292Drug level decreasedFAERS: 1US FAERS
293DysgraphiaFAERS: 1US FAERS
294Ear congestionFAERS: 1US FAERS
295Echocardiogram abnormalFAERS: 1US FAERS
296EczemaFAERS: 1SIDER
US FAERS
297Electrocardiogram U-wave abnormalityFAERS: 1US FAERS
298Endodontic procedureFAERS: 1US FAERS
299Epigastric discomfortFAERS: 1US FAERS
300Exfoliative rashFAERS: 1US FAERS
301Eye inflammationFAERS: 1US FAERS
302Eyelids pruritusFAERS: 1US FAERS
303Facial PainFAERS: 1US FAERS
304Feeling ColdFAERS: 1US FAERS
305Feeling jitteryFAERS: 1US FAERS
306Fibrin D dimer increasedFAERS: 1US FAERS
307Flank PainFAERS: 1US FAERS
308Fluid imbalanceFAERS: 1US FAERS
309FlushingFAERS: 1US FAERS
310FractureFAERS: 1US FAERS
311Gait inabilityFAERS: 1US FAERS
312Gastric BypassFAERS: 1US FAERS
313GastroenteritisFAERS: 1US FAERS
314Gastrointestinal PainFAERS: 1SIDER
US FAERS
315General physical condition decreasedFAERS: 1US FAERS
316GoutFAERS: 1US FAERS
317Hepatic EncephalopathyFAERS: 1US FAERS
318Hepatic necrosisFAERS: 1US FAERS
319Hepatitis BFAERS: 1US FAERS
320HerniaFAERS: 1US FAERS
321High density lipoprotein increasedFAERS: 1US FAERS
322Hip surgeryFAERS: 1US FAERS
323HypercreatininaemiaFAERS: 1US FAERS
324Hypertrophic CardiomyopathyFAERS: 1US FAERS
325Hypoaesthesia facialFAERS: 1US FAERS
326IleusFAERS: 1US FAERS
327Incorrect route of drug administrationFAERS: 1US FAERS
328Incorrect storage of drugFAERS: 1US FAERS
329InflammationFAERS: 1US FAERS
330Inflammatory marker increasedFAERS: 1US FAERS
331Intentional product use issueFAERS: 1US FAERS
332Intestinal ObstructionFAERS: 1US FAERS
333Intestinal infarctionFAERS: 1US FAERS
334Iridocorneal endothelial syndromeFAERS: 1US FAERS
335Irritable Bowel SyndromeFAERS: 1US FAERS
336Lactose IntoleranceFAERS: 1US FAERS
337LaryngitisFAERS: 1US FAERS
338LeukocytosisFAERS: 1US FAERS
339Limb operationFAERS: 1US FAERS
340Long QT SyndromeFAERS: 111723026CTD
US FAERS
341Low density lipoprotein increasedFAERS: 1US FAERS
342Lower respiratory tract infectionFAERS: 1US FAERS
343Lung cystFAERS: 1US FAERS
344LymphomaFAERS: 1US FAERS
345Mastication disorderFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
346Medication residueFAERS: 1US FAERS
347Metabolic acidosisFAERS: 1US FAERS
348Middle insomniaFAERS: 1US FAERS
349Mixed liver injuryFAERS: 1US FAERS
350Muscle tightnessFAERS: 1US FAERS
351Musculoskeletal PainFAERS: 1US FAERS
352Musculoskeletal stiffnessFAERS: 1US FAERS
353MyoclonusFAERS: 1US FAERS
354Neck PainFAERS: 1US FAERS
355Negative cardiac inotropic effectFAERS: 1US FAERS
356Neutrophil count decreasedFAERS: 1US FAERS
357OnycholysisFAERS: 1US FAERS
358Optic AtrophyFAERS: 1US FAERS
359Oropharyngeal swellingFAERS: 1US FAERS
360OsteomyelitisFAERS: 1US FAERS
361OverweightFAERS: 1US FAERS
362Oxygen consumption increasedFAERS: 1US FAERS
363Pancreatic CystFAERS: 1US FAERS
364Pancreatic enzymes increasedFAERS: 1US FAERS
365PanophthalmitisFAERS: 1US FAERS
366ParanoiaFAERS: 1US FAERS
367Pathological fractureFAERS: 1US FAERS
368Performance status decreasedFAERS: 1US FAERS
369PericarditisFAERS: 1US FAERS
370Perirectal abscessFAERS: 1US FAERS
371PhotodermatosisFAERS: 1US FAERS
372PolyarthritisFAERS: 1US FAERS
373Poor quality sleepFAERS: 1US FAERS
374Post procedural complicationFAERS: 1US FAERS
375Prescribed underdoseFAERS: 1US FAERS
376Primary Biliary CholangitisFAERS: 1US FAERS
377Product administration errorFAERS: 1US FAERS
378Product contaminationFAERS: 1US FAERS
379Product difficult to swallowFAERS: 1US FAERS
380Product physical issueFAERS: 1US FAERS
381Product prescribing errorFAERS: 1US FAERS
382Product storage errorFAERS: 1US FAERS
383Product substitution issueFAERS: 1US FAERS
384Product tamperingFAERS: 1US FAERS
385Product taste abnormalFAERS: 1US FAERS
386Product use in unapproved indicationFAERS: 1US FAERS
387Product use issueFAERS: 1US FAERS
388ProteinuriaFAERS: 1US FAERS
389PsoriasisFAERS: 1US FAERS
390Reaction to drug excipientsFAERS: 1US FAERS
391Reaction to preservativesFAERS: 1US FAERS
392Renal cystFAERS: 1US FAERS
393Respiratory arrestFAERS: 1US FAERS
394RestlessnessFAERS: 1US FAERS
395Restrictive cardiomyopathyFAERS: 1US FAERS
396Retinal DetachmentFAERS: 1US FAERS
397Rheumatoid ArthritisFAERS: 1US FAERS
398Saliva alteredFAERS: 1US FAERS
399SciaticaFAERS: 1US FAERS
400SerositisFAERS: 1US FAERS
401Skin hypertrophyFAERS: 1US FAERS
402Skin irritationFAERS: 1US FAERS
403SneezingFAERS: 1US FAERS
404Splenic cystFAERS: 1US FAERS
405Stevens-Johnson SyndromeFAERS: 1US FAERS
406Sudden Cardiac DeathFAERS: 1US FAERS
407TenosynovitisFAERS: 1US FAERS
408Therapeutic procedureFAERS: 1US FAERS
409Therapeutic response changedFAERS: 1US FAERS
410Therapeutic response delayedFAERS: 1US FAERS
411Therapy changeFAERS: 1US FAERS
412Throat clearingFAERS: 1US FAERS
413Thyroid hormones increasedFAERS: 1US FAERS
414TonsillitisFAERS: 1US FAERS
415Toxic Epidermal NecrolysisFAERS: 1US FAERS
416Troponin increasedFAERS: 1US FAERS
417UlcerFAERS: 1US FAERS
418Urinary IncontinenceFAERS: 1US FAERS
419Urinary RetentionFAERS: 1US FAERS
420Urine flow decreasedFAERS: 1US FAERS
421Urine output increasedFAERS: 1US FAERS
422VIIth nerve paralysisFAERS: 1US FAERS
423Vibratory sense increasedFAERS: 1US FAERS
424Vitamin D DeficiencyFAERS: 1US FAERS
425White blood cell count decreasedFAERS: 1US FAERS
426Wound infection pseudomonasFAERS: 1US FAERS
427intensive careFAERS: 1US FAERS
428muscle injuryFAERS: 1US FAERS
429treatment failureFAERS: 1US FAERS
430Anaphylactic shockSIDER
431Asthenic conditionsSIDER
432Chemical and Drug Induced Liver Injury23135547
24881592
CTD
433DermatitisSIDER
434Diarrhea19213680CTD
435Dyspeptic signs and symptomsSIDER
436Exanthema19213680CTD
437Heart failure20628043CTD
438Leukocytoclastic vasculitisSIDER
439Liver Failure, Acute20628043CTD
440Product complaintCanada Vigilance: 1Canada Vigilance
441Torsades de Pointes11723026CTD
442Traumatic liver injurySIDER
443nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.